Identifying risk factors for complications after liver transplantation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to enhance outcomes for patients undergoing related liver transplantation by identifying predictors of thrombohemorrhagic complications. It focuses on patients with end-stage liver cirrhosis and seeks to optimize a comprehensive prevention program for these complications. The study will involve monitoring and analyzing various risk factors that may influence the hemostatic system post-transplantation. By understanding these factors, the study hopes to improve patient care and outcomes following liver transplantation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age over 18 years and up to 70 years;
* Signed informed consent for inclusion to the study;
* End stage liver cirrhosis.

Exclusion Criteria:

* Pregnancy;
* Extrahepatic factors influencing systemic hemostasis;
* Concomitant hematological diseases affecting the hemostatic system;
* Severe concomitant disorders.

Where it's running

• Republican specialized scientific and practical medical center of surgery named after academician V.Vakhidov
  Tashkent, Uzbekistan Recruiting

Study contacts

• Study coordinator: Azam Babadjanov, Professor
• Email: azambabadjanov@gmail.com
• Phone: +998901751703

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Liver transplantation outcomes for patients with severe liver failure

  This study is testing how well liver transplants work for people with severe liver failure compared to those with advanced cirrhosis to see which group has better survival rates and quality of life after the transplant.

  Recruiting at 69 sites European Foundation for Study of Chronic Liver Failure · Los Angeles, California and 105 other locations · NCT04613921

• Using spleen size to help detect gastroesophageal varices in compensated cirrhosis

  This study tests whether ultrasound measurements of spleen size can help identify esophageal varices in adults with compensated cirrhosis, compared with the standard endoscopy test.

  Recruiting Fifth Affiliated Hospital, Sun Yat-Sen University · Zhuhai, Guangdong · NCT07920744

• Laparoscopic liver and spleen removal for small liver cancer in people with cirrhosis and enlarged spleen

  This study tests whether removing part of the liver and the spleen during one operation helps people with small liver cancers and hypersplenism by improving liver function and immune balance.

  Recruiting Northern Jiangsu People's Hospital · Yangzhou, Jiangsu · NCT07811687

• Coil-assisted small-diameter stent shunt reduction for refractory HE after TIPS

  A coil-assisted, small-diameter covered-stent technique is being tested to see if it can safely and effectively reduce shunt flow and lessen recurrent hepatic encephalopathy in people with a prior TIPS.

  Recruiting Air Force Military Medical University, China · Xi'an, Shaanxi · NCT07799948

• Expanding HIV-positive donor livers for HIV-positive recipients

  This study tests whether liver transplants from HIV-positive donors to HIV-positive recipients are safe regarding opportunistic infections and cancer.

  Recruiting at 2 sites National Institute of Allergy and Infectious Diseases (NIAID) · Baltimore, Maryland and 1 other locations · NCT07778459

• Magnetic Resonance Cholangiopancreatography to help living liver donors and their recipients

  This study tests whether preoperative MRCP imaging can help select living liver donors and reduce biliary complications in recipients.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi · NCT07715500

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.